NCT03946124View on ClinicalTrials.gov

Fall Prevention in Older Adults With OAB

PHASE4CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

July 25, 2015

Primary Completion Date

July 19, 2017

Study Completion Date

July 19, 2017

Conditions
Overactive Bladder
Interventions
DRUG

Fesoterodine

Fesoterodine, the drug used in this study, is an appropriate medication for routine and standard care of overactive bladder.

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University of Pennsylvania

OTHER

NCT03946124 - Fall Prevention in Older Adults With OAB | Biotech Hunter | Biotech Hunter